Solutions Ecosystems Reports Resources Data Pricing Login Book a demo
Power Law company profile

Exact Sciences

Biotech & Life Sciences · Madison, United States · Founded 1995 · IPO 2001 Decacorn

Developer and manufacturer of cologuard, a non-invasive screening test for the early detection of colorectal cancer

Valuation
$22B
Market cap · Mar/2026
Revenue
$3.25B
Latest reported FY
EBITDA
$18M
Latest reported FY
Featured in Decacorn$10B+ valuation tier · Power Law dataset 2026 $10B+ revenueThoroughbred · Power Law outcome

Investors

5 investors on Exact Sciences's cap table

Sourced from Dealroom's funding history. Investor profile links are shown where available.

Series A 5 investors entered at this stage
Stan Lapidus
Greylock Partners
DCF Capital
OneLiberty Ventures
Highland Capital

Exact Sciences mafia

Startups founded by Exact Sciences alumni

Former Exact Sciences employees who went on to start their own companies. Sorted by Dealroom signal score.

Predictive BiosciencesEst. 2006
ASAnthony P. ShuberUnited States
Signal score58
SynapDxEst. 2010
Jeffery LuberUnited States
Signal score58
LS9Est. 2005
Noubar AfeyanUnited States
Signal score55
Gregor DiagnosticsEst. 2016
Tobias ZutzUnited States
Signal score55

Book a demo to explore the full alumni network →

Global footprint

Where Exact Sciences has talent and traffic

AI talent share
0.8% of workforce is AI talent
(45 of 5,446 staff)
Core AI150.28%
Other AI300.55%
Non-AI workforce5,40199.17%
Workforce by country
26 countries with
team presence
🇺🇸 United States93.1%
🇨🇭 Switzerland1.3%
🇵🇱 Poland1.2%
🇩🇪 Germany0.7%
🇬🇧 United Kingdom0.7%
Top 5 of 26 shown
Web traffic by country
680K monthly visits
across markets
🇺🇸 United States92.9%
🇨🇦 Canada1.1%
🇬🇧 United Kingdom1%
🇦🇺 Australia0.7%
🇩🇪 Germany0.4%
Top 5 markets shown

Patent intelligence

$319M patent portfolio · 153 active families

Estimated portfolio value
$319M
1.5% of market cap · 2.2× the top peer Zymeworks ($143M)
153 active patent families
Where Exact Sciences innovates OncologyCancer researchPathologyCarcinosisBiology

Where Exact Sciences concentrates vs peers

Each axis is a top-10 topic across Exact Sciences and its closest peers. #1 = 100, #10 = 10, absent = 0.

Compare against

Source: Dealroom Patent Intelligence · Patsnap. Request a demo for the full per-sub-category breakdown, individual records, and quality-score history.

Capital deployed

Exact Sciences's 55 investments and acquisitions.

Every disclosed deal where Exact Sciences appeared as a backer or acquirer, 2017–2026. Toggle between venture rounds, M&A, or both. The map below is grouped by the target company's sector — the colored pill on each chip is the round type.

Portfolio analysis

55 deals across Exact Sciences's capital deployment.

Where the deals concentrate by sector, stage, and decade.

By sectorCount
    By stageCount
      By periodCount

        01 · Deployment strategy vs peers

        Where Exact Sciences deploys vs peers

        Each axis is a Dealroom topic tag — picked from the cluster's most-tagged themes. Values are normalized per axis: the peer with the highest tag-coverage on that axis sits at the edge, others scale relative to them. Toggle between M&A, venture, or both.

        Compare against

        02 · Portfolio market map

        Exact Sciences's portfolio, mapped.

        Each chip is one company. Pill colour shows round type — green for Seed, blue for Series A, purple for B/C+, pink for late-stage, amber for M&A. Bigger sectors keep their full list behind “+ N more”.

        Stage
        Period
        55 of 55 deals

        Market sentiment

        What the market is saying about Exact Sciences

        An AI-synthesized read of the highest-engagement posts about Exact Sciences on X over the past 7 days. We rank by likes & retweets, ignore corporate channels, and surface the themes that broke out from real people.

        Reading the room on X — pulling top posts and synthesizing themes…

        Source: X recent search ranked by engagement (likes + retweets) · Synthesis by Claude · Cached for 1 hour

        See Exact Sciences on the full Dealroom platform

        Live deal flow, founder pedigree, hiring signals, revenue trajectory, and the full cap table.

        Book a demo Explore company profiles